|Bid||170.55 x 0|
|Ask||170.70 x 0|
|Day's Range||166.75 - 170.85|
|52 Week Range||76.92 - 170.85|
|Beta (3Y Monthly)||1.28|
|PE Ratio (TTM)||45.10|
|Forward Dividend & Yield||1.00 (0.60%)|
|1y Target Est||87.86|
In this article we are going to estimate the intrinsic value of Getinge AB (STO:GETI B) by taking the expected future...
The big shareholder groups in Getinge AB (STO:GETI B) have power over the company. Institutions will often hold stock...
Stocks with market capitalization between $2B and $10B, such as Getinge AB (STO:GETI B) with a size of kr41b, do not...
If you're interested in Getinge AB (STO:GETI B), then you might want to consider its beta (a measure of share price...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than...
Troubled Swedish medical technology group Getinge reported an unexpected gain in fourth-quarter core profit on a stronger margin, and forecast an increase in sales in 2019, sending its shares soaring more than 12 percent. Adjusted profit before interest, tax and amortization was 1.41 billion crowns (118.50 million pounds) compared with 1.38 billion crowns a year ago and a Reuters poll forecast of 1.28 billion. "We see signs of margins starting to improve – the adjusted gross margin was, for the first time in 2018, sequentially higher, albeit only slightly.